AU2001241783A1 - Affinity matrix bearing tumor-associated antigens - Google Patents

Affinity matrix bearing tumor-associated antigens

Info

Publication number
AU2001241783A1
AU2001241783A1 AU2001241783A AU4178301A AU2001241783A1 AU 2001241783 A1 AU2001241783 A1 AU 2001241783A1 AU 2001241783 A AU2001241783 A AU 2001241783A AU 4178301 A AU4178301 A AU 4178301A AU 2001241783 A1 AU2001241783 A1 AU 2001241783A1
Authority
AU
Australia
Prior art keywords
associated antigens
affinity matrix
bearing tumor
matrix bearing
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001241783A
Inventor
Samuel J. Danishefsky
Kenneth O. Lloyd
Zhi-Guang Wang
Lawrence J. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sloan Kettering Institute for Cancer Research
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of AU2001241783A1 publication Critical patent/AU2001241783A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/32—Galactans, e.g. agar, agarose, agaropectin, carrageenan

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2001241783A 2000-02-29 2001-02-27 Affinity matrix bearing tumor-associated antigens Abandoned AU2001241783A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18588700P 2000-02-29 2000-02-29
US60185887 2000-02-29
PCT/US2001/006183 WO2001065261A1 (en) 2000-02-29 2001-02-27 Affinity matrix bearing tumor-associated antigens

Publications (1)

Publication Number Publication Date
AU2001241783A1 true AU2001241783A1 (en) 2001-09-12

Family

ID=22682823

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001241783A Abandoned AU2001241783A1 (en) 2000-02-29 2001-02-27 Affinity matrix bearing tumor-associated antigens

Country Status (4)

Country Link
US (1) US20020006629A1 (en)
AU (1) AU2001241783A1 (en)
CA (1) CA2401580A1 (en)
WO (1) WO2001065261A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7824687B2 (en) 1999-08-20 2010-11-02 Sloan-Kettering Institute For Cancer Research Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof
US7879335B1 (en) 1999-08-20 2011-02-01 Sloan-Kettering Institute For Cancer Research Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
US7854934B2 (en) 1999-08-20 2010-12-21 Sloan-Kettering Institute For Cancer Research Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
AT500648B1 (en) * 2002-08-12 2010-03-15 Igeneon Krebs Immuntherapie SET FOR THE TREATMENT OF CANCER PATIENTS
WO2005037261A1 (en) * 2003-10-14 2005-04-28 Biomira, Inc. Combination therapy for cancer
CN1619310A (en) * 2004-11-03 2005-05-25 东南大学 Preparation method of tumour immune cell detecting chip and its detecting method
CA2728344A1 (en) * 2008-06-16 2010-01-14 Academia Sinica Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment
ES2477549T3 (en) * 2008-06-16 2014-07-17 Academia Sinica Cancer diagnosis according to the concentration of antibodies against Globo H and its fragments
US9598466B2 (en) 2008-07-11 2017-03-21 Sloan-Kettering Institute For Cancer Research Glycopeptide constructs and uses thereof
GB0905076D0 (en) * 2009-03-24 2009-05-06 Total Scient Ltd Diagnostic kits and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2403098A1 (en) * 1977-09-19 1979-04-13 Merieux Inst NEW MATERIAL CAPABLE OF REVERSIBLE BINDING OF BIOLOGICAL MACROMOLECULES, ITS PREPARATION AND APPLICATION
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US4849509A (en) * 1987-02-20 1989-07-18 The Wistar Institute Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies
US5034516A (en) * 1987-08-04 1991-07-23 University Of Ottawa Synthetic antigens of sialic acid and derivatives thereof

Also Published As

Publication number Publication date
WO2001065261A1 (en) 2001-09-07
US20020006629A1 (en) 2002-01-17
CA2401580A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
AU2002351623A1 (en) Streptococcus antigens
AU2002244694A1 (en) Symbiotic regenerative agent
AUPQ600100A0 (en) Animation technology
AU2001275744A1 (en) Bearing arrangement
AUPQ998100A0 (en) Application development
AU4935000A (en) Antibodies
AU2002212018A1 (en) Service enabling technology
AU2002365649A1 (en) Anti-dota antibody
AU7540900A (en) Affinity macroligands
AU2002354219A1 (en) Composition for friction material and friction material using the composition
AU2001278405A1 (en) Floating bearing
AU2001284222A1 (en) Pivot bearing
AU2001280590A1 (en) 5-substituted 2-aryl-4-pyrimidinones
AU2001242478A1 (en) Magnetic, silanised polyvinylalcohol-basedcarrier materials
AU2001246934A1 (en) Agonist antibodies
AU2001294376A1 (en) Dextran hydrogels
AU2001241783A1 (en) Affinity matrix bearing tumor-associated antigens
AU2002357891A1 (en) Dtat fusion toxin
AU6278300A (en) Tumor-associated antigen (r11)
AU2001242771A1 (en) Center bearing support
AU2001289307A1 (en) Chemically-modified myelopoietin conjugates
AU3283500A (en) Tumor-associated antigen
AU2002221132A1 (en) Novel antibody
AUPQ504000A0 (en) Brake assembly
AU5169400A (en) Personalized metabrowser